Vyome Holdings Inc (HIND)

$8.09 +0.14 (1.76%)
Market Cap 5.35M
Revenue (ttm) 8.01M
Net Income (ttm) -7.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.01%
Debt to Equity Ratio 0.00
Volume 32,900
Avg Vol 376,951
Day's Range N/A - N/A
Shares Out 673,000.00
Stochastic %K 9%
Beta 1.02
Analysts Hold
Price Target N/A

Company Profile

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Industry: Biotechnology
Sector: Healthcare
Phone: 973 832 8147
Address:
100, Overlook Center, 2nd Floor, Princeton, United States
Crystalgator
Crystalgator Sep. 4 at 7:08 PM
$HIND omg. this is down to post merger lows on news? frightening
0 · Reply
BioTuesdays
BioTuesdays Sep. 4 at 5:27 PM
$HIND has announced the interim results from its investigator –initiated Phase 2 Proof of Concept study of VT-1953 topical gel in patients with malignant fungating wounds (MFW). https://biotuesdays.com/2025/09/04/vyome-announces-positive-interim-data-on-vt-1953-in-mfw/
0 · Reply
uncreativeone
uncreativeone Sep. 4 at 5:25 PM
$HIND https://www.businesswire.com/news/home/20250904730668/en/Vyome-Holdings-Announces-Positive-Interim-Data-from-Phase-2-Study-of-VT-1953-in-Malignant-Fungating-Wounds-MFW-and-Provides-Update-on-MFW-market-opportunity
1 · Reply
Crystalgator
Crystalgator Sep. 2 at 4:39 PM
$HIND it's still above $8? i am surprised it lasted this long. don't worry, we'll be in the $7's shortly
0 · Reply
nestlk1
nestlk1 Aug. 31 at 2:04 PM
$HIND Have we heard the last of rsls?
0 · Reply
Crystalgator
Crystalgator Aug. 29 at 4:55 PM
$HIND lmao. this piece of garbage is going to $5 soon. they got nothing but shares for sale
0 · Reply
knowithall
knowithall Aug. 29 at 12:20 AM
$HIND Now that Vyome is a public company (HIND). H ow will they raise the money for Phase 3 trials for VB-1953 gel? This P3 trail has been on hold for over 5 years due to lack of funding. Does anyone know what their cash position is now based on the merger shares? Or would they need to do an offering to raise the cash? Thoughts?
3 · Reply
HumanityFirst
HumanityFirst Aug. 28 at 10:25 PM
$HIND I grabbed the dip 😆
0 · Reply
HumanityFirst
HumanityFirst Aug. 28 at 5:57 PM
$HIND well, I entered a position. I expect this yo go back to 12+ next week.
0 · Reply
Whatif_hellomat8s
Whatif_hellomat8s Aug. 28 at 5:36 PM
$HIND same here no records of me buying
2 · Reply
Latest News on HIND
Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity

Sep 4, 2025, 8:30 AM EDT - 4 days ago

Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity

Vyome Signs MoU with Embryyo, India's Leading Medical Device Innovation Studio

Aug 21, 2025, 7:00 AM EDT - 18 days ago

Vyome Signs MoU with Embryyo, India's Leading Medical Device Innovation Studio

Vyome Announces Strategic Review of Livechain (OTCID: LICH)

Aug 18, 2025, 8:30 AM EDT - 21 days ago

Vyome Announces Strategic Review of Livechain (OTCID: LICH)

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell

Aug 15, 2025, 8:00 AM EDT - 24 days ago

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

Aug 14, 2025, 7:18 PM EDT - 25 days ago

Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

RSLS

Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND

Aug 13, 2025, 11:50 AM EDT - 26 days ago

Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND

RSLS

Vyome Announces New Board of Directors with Deep MIT and AI Ties

Aug 12, 2025, 9:48 AM EDT - 27 days ago

Vyome Announces New Board of Directors with Deep MIT and AI Ties

RSLS

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics

Aug 7, 2025, 5:01 PM EDT - 4 weeks ago

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics

RSLS

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders

Jul 24, 2025, 4:39 PM EDT - 6 weeks ago

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders

RSLS

ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit

Jul 22, 2025, 8:31 AM EDT - 6 weeks ago

ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit

RSLS

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025

Jul 21, 2025, 2:10 PM EDT - 7 weeks ago

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025

RSLS

ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System

Jul 1, 2025, 8:31 AM EDT - 2 months ago

ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System

RSLS

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

Jun 27, 2025, 9:01 AM EDT - 2 months ago

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

RSLS

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys

Jun 26, 2025, 8:31 AM EDT - 2 months ago

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys

RSLS

ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology

Jun 25, 2025, 8:31 AM EDT - 2 months ago

ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology

RSLS

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets

Jun 12, 2025, 8:25 AM EDT - 3 months ago

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets

RSLS

ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering

Jun 9, 2025, 9:00 AM EDT - 3 months ago

ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering

RSLS

ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio

Jun 3, 2025, 8:31 AM EDT - 3 months ago

ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio

RSLS

ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update

May 21, 2025, 8:31 AM EDT - 3 months ago

ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update

RSLS

Orla Mining, ReShape Lifesciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

May 12, 2025, 8:32 AM EDT - 4 months ago

Orla Mining, ReShape Lifesciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

ORLA RSLS

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split

May 7, 2025, 8:31 AM EDT - 4 months ago

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split

RSLS

ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium

May 2, 2025, 8:31 AM EDT - 4 months ago

ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium

RSLS

ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System

Apr 28, 2025, 8:31 AM EDT - 4 months ago

ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System

RSLS

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology

Apr 21, 2025, 8:31 AM EDT - 5 months ago

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology

RSLS

ReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript)

Apr 10, 2025, 5:54 PM EDT - 5 months ago

ReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript)

RSLS

ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market

Apr 9, 2025, 4:05 PM EDT - 5 months ago

ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market

RSLS

ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update

Apr 7, 2025, 4:05 PM EDT - 5 months ago

ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update

RSLS

RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS

Mar 21, 2025, 11:35 AM EDT - 6 months ago

RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS

RSLS

ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology

Mar 10, 2025, 8:31 AM EDT - 6 months ago

ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology

RSLS

ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX

Feb 25, 2025, 8:31 AM EST - 6 months ago

ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX

RSLS

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

Feb 15, 2025, 11:17 PM EST - 7 months ago

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

RSLS

ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology

Feb 3, 2025, 8:31 AM EST - 7 months ago

ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology

RSLS

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

Jan 13, 2025, 8:31 AM EST - 8 months ago

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

RSLS

ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 7:43 PM EST - 10 months ago

ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript

RSLS

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

Nov 12, 2024, 4:05 PM EST - 10 months ago

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

RSLS

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

Nov 12, 2024, 8:31 AM EST - 10 months ago

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

RSLS

ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape's Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology

Nov 11, 2024, 8:31 AM EST - 10 months ago

ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape's Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology

RSLS

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

Sep 19, 2024, 8:31 AM EDT - 1 year ago

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

RSLS

ReShape Lifesciences Inc. (RSLS) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 8:42 PM EDT - 1 year ago

ReShape Lifesciences Inc. (RSLS) Q2 2024 Earnings Call Transcript

RSLS

ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

Aug 13, 2024, 8:31 AM EDT - 1 year ago

ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

RSLS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders

Jul 19, 2024, 8:05 AM EDT - 1 year ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders

CHUY RSLS

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”

Jul 9, 2024, 12:13 PM EDT - 1 year ago

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”

RSLS

ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

Jul 9, 2024, 8:31 AM EDT - 1 year ago

ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

RSLS

ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call Transcript

May 17, 2024, 8:57 PM EDT - 1 year ago

ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call Transcript

RSLS

ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update

May 15, 2024, 4:05 PM EDT - 1 year ago

ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update

RSLS

ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

May 14, 2024, 8:31 AM EDT - 1 year ago

ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

RSLS

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update

Apr 1, 2024, 4:05 PM EDT - 1 year ago

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update

RSLS

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

Mar 28, 2024, 8:31 AM EDT - 1 year ago

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

RSLS

ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX

Mar 4, 2024, 8:31 AM EST - 1 year ago

ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX

RSLS

Crystalgator
Crystalgator Sep. 4 at 7:08 PM
$HIND omg. this is down to post merger lows on news? frightening
0 · Reply
BioTuesdays
BioTuesdays Sep. 4 at 5:27 PM
$HIND has announced the interim results from its investigator –initiated Phase 2 Proof of Concept study of VT-1953 topical gel in patients with malignant fungating wounds (MFW). https://biotuesdays.com/2025/09/04/vyome-announces-positive-interim-data-on-vt-1953-in-mfw/
0 · Reply
uncreativeone
uncreativeone Sep. 4 at 5:25 PM
$HIND https://www.businesswire.com/news/home/20250904730668/en/Vyome-Holdings-Announces-Positive-Interim-Data-from-Phase-2-Study-of-VT-1953-in-Malignant-Fungating-Wounds-MFW-and-Provides-Update-on-MFW-market-opportunity
1 · Reply
Crystalgator
Crystalgator Sep. 2 at 4:39 PM
$HIND it's still above $8? i am surprised it lasted this long. don't worry, we'll be in the $7's shortly
0 · Reply
nestlk1
nestlk1 Aug. 31 at 2:04 PM
$HIND Have we heard the last of rsls?
0 · Reply
Crystalgator
Crystalgator Aug. 29 at 4:55 PM
$HIND lmao. this piece of garbage is going to $5 soon. they got nothing but shares for sale
0 · Reply
knowithall
knowithall Aug. 29 at 12:20 AM
$HIND Now that Vyome is a public company (HIND). H ow will they raise the money for Phase 3 trials for VB-1953 gel? This P3 trail has been on hold for over 5 years due to lack of funding. Does anyone know what their cash position is now based on the merger shares? Or would they need to do an offering to raise the cash? Thoughts?
3 · Reply
HumanityFirst
HumanityFirst Aug. 28 at 10:25 PM
$HIND I grabbed the dip 😆
0 · Reply
HumanityFirst
HumanityFirst Aug. 28 at 5:57 PM
$HIND well, I entered a position. I expect this yo go back to 12+ next week.
0 · Reply
Whatif_hellomat8s
Whatif_hellomat8s Aug. 28 at 5:36 PM
$HIND same here no records of me buying
2 · Reply
Logan12071
Logan12071 Aug. 28 at 5:16 PM
$HIND why was I just given a share of this stock …
1 · Reply
skunktrades
skunktrades Aug. 28 at 4:58 PM
$HIND market cap discounted 10x 🤔
0 · Reply
HumanityFirst
HumanityFirst Aug. 28 at 3:40 PM
$HIND how is there volume with no news?
2 · Reply
HumanityFirst
HumanityFirst Aug. 27 at 7:29 PM
$HIND whats the upsell? Any news?
0 · Reply
BullionSentinel
BullionSentinel Aug. 27 at 7:19 AM
$HIND choppy movement, waiting for clearer direction.
0 · Reply
HumanityFirst
HumanityFirst Aug. 27 at 4:52 AM
$HIND Trade with caution. Think big casino with everything rigged pro-house.
0 · Reply
_Leviathan_
_Leviathan_ Aug. 26 at 5:17 PM
$HIND what little vol and most is dark pool
1 · Reply
Vaprtrl
Vaprtrl Aug. 26 at 2:08 AM
$HIND so this is the old rsls? Gotta research what is going on here now. I really liked the product line and possibilities. Hope y’all made bank from the merger. How did that work with your shares?
1 · Reply
HumanityFirst
HumanityFirst Aug. 25 at 3:40 PM
$HIND I will reenter if hit under 8$
1 · Reply
OatesTheGoat
OatesTheGoat Aug. 25 at 1:46 PM
$HIND 20% so far, looking for $12 break for continuation
0 · Reply
MrStealYoMoney
MrStealYoMoney Aug. 25 at 10:38 AM
$HIND $SPY
0 · Reply
MrStealYoMoney
MrStealYoMoney Aug. 25 at 8:51 AM
$HIND $SPY Direct Saudi side. Call out. You missed again. Checkmate losers.
0 · Reply